March 14, 2025

Post-Pandemic Health Ratings Plummet

Americans report record-low mental and physical health assessments in Gallup survey, with young women experiencing steepest mental health decline since the COVID-19 pandemic began despite end of public health emergency.

Conexiant

March 13, 2025

Sedentary Time and Anxiety: Walking’s Role in Risk Reduction

Researchers identified a J-shaped dose–response relationship, with minimal anxiety risk at six sedentary hours per day but a steep increase beyond this threshold, while walking for more than ten minutes on most days mitigated this effect.

Conexiant

March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 12, 2025

Prescribing Culture: Doctors Embrace Museum Therapy

"I'm convinced that when we take care of people's emotions, we allow them somehow to perhaps find a path to healing."

Reuters

March 12, 2025

Medical Oddities: Herpes Up the Nose, Trouble for the Brain

Herpes entering through the nose smells like trouble for the brain. Mangos may have a seat at the metabolic table. And humans don't understand their dogs as much as they think they do. We dive into these studies and more.

Conexiant

March 10, 2025

Childhood Cancer Survivors Face Higher Risk of Suicidal Ideation

"The prevalence of mental health conditions is higher among CCSs compared with the general population."

Conexiant

March 10, 2025

New Study Ties Sleep Loss to Binge Eating

Researchers recommend that clinicians screen adolescents for both conditions.

Conexiant

March 07, 2025

New Clinical Guideline for Benzodiazepine Tapering Released

The new clinical practice guideline, developed in tandem by representatives from 10 medical societies, provides evidence-based and consensus recommendations for safe benzodiazepine tapering when risks outweigh benefits.

Conexiant

March 07, 2025

Novel Therapies Advance Psychiatric Treatment Options

New research has found intranasally administered esketamine's effects are short-lived. tDCS shows promise for depression, ondansetron has limited OCD impact, and Cobenfy enhances cognition in schizophrenia.

Conexiant